InvestSMART

Cambium Bio Limited (ASX: CMB) - Announcements

- Current share price for CMB : $0.410

ASX company news and announcements for Cambium Bio Limited (CMB) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Cambium Bio Limited (CMB) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Cambium Bio Limited (CMB), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Cambium Bio Limited (CMB)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$12 Placement Shares Cleansing Notice 12 Dec 2024 3:30PM $0.540 $0.410 fallen by 24.07%
$12 Application for quotation of securities - CMB 12 Dec 2024 3:29PM $0.540 $0.410 fallen by 24.07%
$12 FDA Grants Fast Track Designation 9 Dec 2024 10:56AM $0.625 $0.410 fallen by 34.40%
$12 Proposed issue of securities - CMB 5 Dec 2024 1:07PM $0.625 $0.410 fallen by 34.40%
$12 Cambium Bio Successfully Closes A$3.0M Financing Round 5 Dec 2024 10:11AM $0.640 $0.410 fallen by 35.94%
$12 Trading Halt 2 Dec 2024 5:03PM $0.640 $0.410 fallen by 35.94%
$12 AGM results and Re-appointment of Dr Bala 26 Nov 2024 3:39PM $0.570 $0.410 fallen by 28.07%
$12 Cambium AGM CEO address 26 Nov 2024 10:54AM $0.560 $0.410 fallen by 26.79%
$12 Proposed issue of securities - CMB 22 Nov 2024 11:05AM $0.520 $0.410 fallen by 21.15%
$12 Cambium Bio Board Changes 22 Nov 2024 9:38AM $0.520 $0.410 fallen by 21.15%
$12 Quarterly Activities/Appendix 4C Cash Flow Report 30 Oct 2024 5:46PM $0.415 $0.410 fallen by 1.20%
$12 Notice of Annual General Meeting/Proxy Form 25 Oct 2024 9:51AM $0.455 $0.410 fallen by 9.89%
$12 CEO Acquires Shares Demonstrating Strong Confidence 15 Oct 2024 12:53PM $0.450 $0.410 fallen by 8.89%
$12 Initial Director's Interest Notice - Chang 10 Oct 2024 12:58PM $0.360 $0.410 risen by 13.89%
$12 Cambium Bio Strengthens Leadership with Two Key Appointments 10 Oct 2024 11:02AM $0.360 $0.410 risen by 13.89%
$12 Date of AGM 2 Oct 2024 5:27PM $0.390 $0.410 risen by 5.13%
$12 CEO Revised Engagement Agreement Terms 30 Aug 2024 2:47PM $0.350 $0.410 risen by 17.14%
$12 Appendix 4G and Corporate Governance Statement 30 Aug 2024 2:28PM $0.350 $0.410 risen by 17.14%
$12 Cambium 4E and Annual Report 30 Aug 2024 2:27PM $0.350 $0.410 risen by 17.14%
$12 Change in substantial holding-Apex 31 Jul 2024 10:45AM $0.400 $0.410 risen by 2.50%
$12 Change in substantial holding-Treasure 31 Jul 2024 10:44AM $0.400 $0.410 risen by 2.50%
$12 Quarterly Activities/Appendix 4C Cash Flow Report 31 Jul 2024 10:37AM $0.400 $0.410 risen by 2.50%
$12 Change in substantial holding 19 Jul 2024 11:00AM $0.410 $0.410 fallen by 0%
$12 Change of Directors Interest 12 Jul 2024 2:43PM $0.400 $0.410 risen by 2.50%
$12 Completion of Share Consolidation 12 Jul 2024 2:11PM $0.400 $0.410 risen by 2.50%

76 - 100 of 128 results

Page 4 of 6

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.